These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33341301)

  • 1. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.
    Cheng C; Cheng GY; Denas G; Pengo V
    Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is known about pediatric antiphospholipid syndrome?
    Meroni PL; Argolini LM; Pontikaki I
    Expert Rev Hematol; 2016 Oct; 9(10):977-85. PubMed ID: 27615277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults.
    Tektonidou MG; Andreoli L; Limper M; Tincani A; Ward MM
    RMD Open; 2019; 5(1):e000924. PubMed ID: 31168416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilemmas in the diagnosis and management of antiphospholipid syndrome.
    Manning JE; Arachchillage DJ
    J Thromb Haemost; 2024 Aug; 22(8):2156-2170. PubMed ID: 38705387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
    Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
    Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathogenesis, diagnosis and treatment of antiphospholipid syndrome].
    Ohmura K; Oku K; Atsumi T
    Nihon Rinsho; 2014 Jul; 72(7):1309-13. PubMed ID: 25163327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.
    Chighizola CB; Ubiali T; Meroni PL
    J Immunol Res; 2015; 2015():951424. PubMed ID: 26075289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome and pregnancy.
    Satta R; Biondi G
    G Ital Dermatol Venereol; 2019 Jun; 154(3):277-285. PubMed ID: 30375212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculitis in antiphospholipid syndrome.
    Lally L; Sammaritano LR
    Rheum Dis Clin North Am; 2015; 41(1):109-23, ix. PubMed ID: 25399943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review.
    Lambert M; Brodovitch A; Mège JL; Bertin D; Bardin N
    Autoimmun Rev; 2024 Jun; 23(6):103585. PubMed ID: 39094811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K
    Pol Arch Med Wewn; 2007; 117 Suppl():41-5. PubMed ID: 18778019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome in children.
    Zajc Avramovic M; Avcin T
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101986. PubMed ID: 39138042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.